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2Abstract:
Renal transplantation can often be complicated due to delayed graft function, which 
is a direct sequel of ischemia reperfusion injury. The adverse outcome of delayed 
graft function is not only short term but the long term function of the graft is also 
affected.  Therefore,  it  is  important  to  understand  the  mechanisms  of  ischemia 
reperfusion  injury.  Reactive  oxygen  species  are  the  key  mediators  in  ischemia 
reperfusion  injury causing  direct  cell  damage which  also  initiate  inflammation  by 
inducing chemokines. Presence of Inflammation is a marker of severe delayed graft 
function.  However,  the  effect  of  oxidative  stress  on  the  expression  of  key 
chemokines has not been fully established yet.
Therefore, the aim of this study was to measure the oxidative stress response and 
the  secretion  of  chemokines  in  a  cell  culture  model  that  mimics  the  effects  of 
ischemia reperfusion injury in immortalised human renal proximal tubular epithelial 
cells, HK-2. 
Cells were treated with varying concentrations of hydrogen peroxide and markers of 
oxidative  stress  response  and  chemokine  release  were  measured.  Exposure  to 
hydrogen peroxide induced a significant increase in the activity of the antioxidant 
enzyme glutathione peroxidase and the levels of the chemokines Interleukin-8 (IL-8;  
CXCL8) and MCP-1 (CCL2). A dose related increase of chemokine secretion was 
also observed. The cytokine Interleukin-1β (IL-1β) at 1ng/ml significantly potentiated 
the expression of both IL-8 (CXCL8) and MCP-1 (CCL2) which showed synergistic 
response in the presence of hydrogen peroxide. Pre-incubation of the cells with the 
anti-oxidant N-acetyl cysteine (NAC) strongly suppressed the induction of both IL-8 
and MCP-1 when stimulated with hydrogen peroxide and IL-1β. 
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3This  study  demonstrates  the  potential  of  anti-oxidants  like  N-acetyl  cysteine  in 
ameliorating  the  effects  of  ischemia  reperfusion  injury  thus  suggesting  a  new 
therapeutic  approach  in  renal  transplantation.  These  findings  can  have  potential 
implications  for  clinical  use  to  prevent  ischemia  reperfusion  injury  in  renal 
transplantation.  
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41. Introduction:
Compared with dialysis,  renal transplantation offers patients with end stage renal 
failure improved survival and quality of life. Delayed graft function (DGF) is a well-
known  complication  affecting the  kidney  allograft  in  the  immediate  post-
transplantation period. The incidence of DGF has been increasing over time from 
14.7% to 21.3% perhaps due to the use of expanded criteria donors (1).  Patients 
with  DGF require  prolonged hospitalisation and rehabilitation, which increase the 
overall  cost of transplantation. Meta-analysis by Yarlagadda et al had shown that 
patients with DGF had a 41% increased risk of graft loss and a higher mean serum 
creatinine. DGF was also associated with a 38% relative increase in the risk of acute 
rejection (2). Halloran et al have reported that the half-life of cadaveric kidneys with 
no delayed graft function was 11·5 years, compared with 7.2 years for those with  
delayed function (3). This makes a compelling case to investigate DGF further and to  
find novel solutions to ameliorate this phenomenon. 
The proximal tubules located in the outer medulla of the kidney are the primary site 
of injury in renal ischemia and reperfusion (4). Under normal physiological conditions 
this region is marginally oxygenated and has a high basal metabolic demand (5),(6). 
Therefore, hypoxic or ischemic injury can cause a significant damage to the proximal 
tubules.
The Ischemia-reperfusion injury (IRI)  is  a highly complex cascade of events that 
includes interactions between the vascular endothelium, interstitial  compartments, 
circulating immune cells, and other biochemical factors. Inflammation is known to be 
a key mediator of IRI and a considerable body of data demonstrates the significance 
of the innate immunity in IRI (7),(8).  The absence of oxygen and nutrients during 
ischemia  creates  a  condition  in  which  the  restoration  of  circulation  results  in 
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5production of Reactive Oxygen Species (ROS) in the proximal tubules. Oxidative 
damage from the ROS increases the local generation of pro-inflammatory cytokines 
and chemokines which recruit neutrophils and lymphocytes at the site of injury and 
lead  to  an  inflammation-like  state.  The  neutrophils  themselves  increase  the 
generation of ROS and also cause direct cellular injury rather than restoration of 
normal function. 
Reactive  oxygen  species  (ROS)  are  known  to  stimulate  the  production  of  key 
transcription factors, growth  factors and inflammatory mediators like  Interleukin-8 
(IL-8; CXCL8), Monocyte chemoattractant protein-1 (MCP-1; CCL2) and Regulated 
on normal T cell expressed and secreted (RANTES; CCL5)(9). These chemokines 
recruit neutrophils and lymphocytes thus leading to subsequent cellular injury (10). 
The chemokines are a family of chemotactic cytokines that act as directional signals 
in the migration of effector leukocytes (11). In addition, chemokines have also been 
shown to activate leukocytes, influence haematopoiesis, and modulate angiogenesis 
(12),(13).
Interleukin-8  (CXCL8)  represents  a  classical  CXC chemokine  which  is  a  potent 
inducer  of  neutrophil  chemotaxis  (14).  It  is  produced  early  in  inflammation  in 
response to stimuli  such as endotoxin and by the early,  alarm cytokines such as 
TNFα and IL-1. Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) is a member of 
the C-C chemokine family, and a potent chemotactic factor for monocytes. CCL2 is 
produced by a variety of cell  types it is one of the key chemokines that regulate 
migration and infiltration of monocytes/macrophages (15). 
Neutrophil  activation in IRI  has been gaining attention in  the past  several  years, 
primarily due to the re-evaluation of the role of excessive inflammatory response in 
kidney IRI. In models of renal IRI, depletion of neutrophils, blockade of neutrophil  
6adhesion to the endothelium, and inhibition of the complement system have shown 
to decrease kidney damage (16). Land et al have demonstrated that changes in the 
expression of chemokine and chemokine receptors following transplantation regulate 
the migration of leukocytes from the peripheral circulation into the allograft (17). The 
role of chemokines in IRI known but its behaviour in proximal tubules is less known.
2. Objectives:
1.  To  measure  oxidative  stress  response  in  a  cell  culture  system  (immortalised 
human renal  proximal  tubular  epithelial  cells  hRPTEC)  in  response to  simulated 
pathological condition of ischemia reperfusion injury.
2. To determine the ability of human tubular cells to produce chemokines in a similar 
setting.
3. To establish the role of oxidative stress on the expression of IL-8 (CXCL8) and 
MCP-1 (CCL2) 
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73. Materials and Methods
Cell culture
HK-2  cells  were  obtained  from  the  American  Type  Culture  Collection  (ATCC, 
Rockville, CRL-2190) and were cultured until 90–95% confluent in six-well plates or 
T75 flasks in DMEM/Ham's F12 growth medium supplemented with 5.5 mM glucose, 
2 mM L-glutamine, 5 µg/ml insulin, 5 µg/ml transferrin, 5 ng/ml sodium selenite, 0.4 
µg/ml hydrocortisone, 5 ng/ml epidermal growth factor, 100 U/ml penicillin, 100 µg/ml 
streptomycin, 20 mM HEPES, and 10% FCS. The growth medium was changed on 
alternate days and the cells were used for no more than 10 passages. HK-2 cells 
cultured with serum were growth arrested for 48h in serum free media (SFM). 
Subculture was performed weekly or when the monolayers reached 80% confluence 
as assessed by phase-contrast microscopy. Cells were maintained in an incubator at 
37°C and 5% CO2. Cell viability was assessed using the Trypan blue exclusion assay 
using 30, 300, 1000 µM H2O2 (18). 
Model for Ischaemia Reperfusion Injury
HK-2 cells were seeded in 6 well culture plates as described previously. Once 80% 
confluence was reached, growth was arrested by incubation in SFM for 24 hrs prior 
to all experiments. The cells were then incubated with 0.5 mM hydrogen peroxide for 
60 minutes at  37°C in  an incubator.  Cells  were then washed with  PBS at  room 
temperature three times and incubated in growth media for 6,12,24, or 36 hours. The 
control group were not exposed to hydrogen peroxide but were given PBS wash to 
keep the conditions similar in both groups. The cells were then harvested at the 
above  stated  time  intervals  to  assess  markers  of  oxidative  stress  catalase  and 
glutathione peroxidise. 
8Model for Chemokine Induction
HK-2 cells were grown as described previously.  Oxidative stress was induced by 
exposure to 30 or 300µM hydrogen peroxide for 60 minutes. The cells were washed 
then three times with PBS and were incubated in SFM for 24hrs. Supernatants were 
collected for IL-8 (CXCL8) and MCP-1 (CCL2) analysis. The cells were harvested in 
sodium hydroxide to  determine the protein  content  which  was analysed by BCA 
(Sigma). 
Model for Chemokine Suppression with NAC
HK-2 cells were grown as described previously. Cells were incubated with 10mM 
NAC for 60 minutes and washed three times with PBS. The control cells were not 
exposed to NAC but received a wash with PBS to keep all conditions similar in both 
sets. Cells were then incubated in 30 and 300μM H2O2 for 60 min. The cells were 
then washed three times with PBS and incubated in SFM for 24 hrs. Supernatants 
were collected and analysed for IL-8 and MCP-1.
Model for Chemokine Induction with IL-1β and NAC Inhibition:
HK-2 cells were cultured as described previously. Cells were incubated with 10mM 
NAC for 60 minutes and washed three times with PBS. The control cells were not 
exposed  to  NAC but  however  received  a  wash  with  PBS to  keep all  conditions 
similar in both sets. Following this some cells were pre-incubated with 1ng/ml IL-1β 
for 24 hrs. Other cells remained in SFM. Cells were then washed three times with 
SFM and incubated in 30 or 300µM H2O2 for 60 min. The cells were washed three 
times with SFM and incubated in SFM for 24 hrs. Supernatants were collected and 
analysed for IL-8 and MCP-1 using ELISAs.
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9Glutathione Peroxidase and Catalase activity assays
Cells were harvested in 550µl of PBS/well and sonicated for 10sec at 15 microns 
(Soniprep 150, Sanyo Scientific). The cell extracts were clarified by centrifugation, 
and the protein content was measured by the bicinchoninic acid method (BCA).  
Glutathione peroxidase (GPx) activity was measured using the method of Flohe and 
Gunzler (19). 
Catalase activity was measured spectrophotometrically using the assay developed 
by Beers and Sizer (20).
IL-8 and MCP-1 ELISA
The media supernatants were collected, clarified from cell debris by centrifugation 
and stored at -20°C prior to analysis.
IL-8  and  MCP-1  levels  were  measured  using  sandwich  ELISA according  to  the 
manufacturer’s protocol (R&D Systems). The ELISA plates were read using a micro 
plate reader (Powerwave X340, Bio-tech Instruments Inc, Vermont,USA) at 450nm 
using background subtraction at 570nm. The concentrations of IL-8 and MCP-1 in 
the supernatants were determined from a standard curve and were normalised using 
the total protein values of the respective cell monolayers.
Data analysis
Statistical  analyses  were  carried  out  using  the  Statistical  Package  for  Social 
Sciences (SPSS version 11.01, Surrey, UK). All data were expressed as means  ± 
SE.  Data were analysed using a one-way repeated measures ANOVA. Where a 
significant value was observed, Tukey’s HSD post hoc analysis was performed to 
identify  where  the  significant  differences  occurred.  A  P  value  of  <0.05  was 
considered significant.
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4. Results:
Cell  viability was assessed using the Trypan blue exclusion assay.  Adherent and 
floating cells were harvested at 24 and 48 hrs after exposure to either SFM alone 
(control)  or  to  Hydrogen  peroxide  preparation.  The  pooled  adherent  and  non-
adherent  cells  remained  viable  both  at  24  and  48  hours  after  exposure  to 
30,300,1000 µM hydrogen peroxide with no significant difference between the three 
groups.(Figure not shown)
Glutathione peroxidase and catalase enzyme activity in response to H2O2
Glutathione peroxidase activity was measured  at 2,4,8,12,24 and 36 hours. There 
was a significant rise in glutathione peroxidase activity in the samples collected after 
36  hours  of  injury  (181.8+/110.61mU/mg  compared  to  95.34+/-23.88mU/mg  in 
control; (p<0.05)), as shown in Figure 1. The experiments were repeated on at least 
three separate occasions.
There was no significant change in the activity of catalase at any time interval (n=12;  
figure not shown). 
 Figure 1:  Glutathione peroxidase (Gpx) activity  in  cell  exposed to 0.5 mM 
hydrogen peroxide (n=6) 
Basal production of IL-8 (CXCL8)
IL-8  (CXCL8)  was detected within 6 hours of incubation in SFM 70.3+/-36.86pg/ml 
and the concentration increased with time, 456.8+/-94.28pg/ml at 12 hours, 925+/-
139pg/ml at 24 hours and 1337+/-158pg/ml at 48 hours (results not shown). Basal 
IL-8 production could be due to the stress of cell culture due to transfer of cells and 
change  in  media.  The  progressive  rise  with  time  is  possibly  the  effect  of 
accumulation. 
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Effect of growth media and hydrogen peroxide on IL-8 (CXCL8):
When exposed to 30 or 300 µM of hydrogen peroxide in growth media or SFM, no 
change in IL-8 (CXC) was observed in cells cultured in growth media. In contrast, 
cells incubated in SFM showed a significant rise in IL-8 (CXCL8) with 300  µM of 
hydrogen peroxide measured at 24 hrs (Figure 2).
The possible explanation for this could be the albumin in foetal calf serum may have 
scavenged the free radicals resulting in reduced stimulation of cells in growth media 
group. Other explanation can be that the cells are less stressed in growth media as 
compared to SFM thus resulting in less stimulation in growth media group. 
                
Figure 2: Induction of IL-8 with 30 and 300µM H2O2 in serum free media but not 
in growth media 
Effect of Interleukin-1beta (IL-1β) on IL-8 (CXCL8) production
HK-2 cells when stimulated with 1ng/ml IL-1β showed an increase in IL-8 (CXCL8) 
production (Figure 3). In the same experiment 30 and 300 µM of hydrogen peroxide 
also increased the production of IL-8 significantly. A further increase in IL-8 (CXCL8) 
was observed in cells  exposed to IL-1β  and then incubated with  30 and 300µM 
hydrogen  peroxide,  (Figure  3).  There  was  no  statistical  difference  between  the 
exposure  to  30  and  300µM  hydrogen  peroxide  alone.  However,  there  was  a 
significant  rise  between  cells  exposed  to  30  or  300  µM hydrogen  peroxide  and 
further stimulated with  IL-1β which was more than expected suggesting synergism 
between IL-1β and hydrogen peroxide. 
 Figure 3: IL-8 induction with IL-1 alone and in combination with H2O2 (n=6) * 
P <0.05
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Effects of N-Acetyl cysteine (NAC) and hydrogen peroxide on IL-8 production 
In HK-2 cells were pre-incubated with NAC 10mM and then stimulated with 
hydrogen peroxide 30 and 300 µM, IL-8 (CXCL8) was inhibited in both 
groups. 4464+/-425pg/ml and 3993+/-1464pg/ml respectively as 
compared to cells not pre-incubated with NAC 5919+/-659pg/ml and 
6865+/-105pg/ml, although this was not statistically significant (p>0.05; 
data not shown).
Effects  of  N-acetyl  cysteine  (NAC)  and  Interleukin-1beta  (IL-1β)  on  IL-8 
production
HK-2 cells when stimulated with 1ng/ml IL-1β significantly increased the  production 
of IL-8 to 7990+/-972pg/ml when compared with control cells that were incubated 
with culture  medium  alone  at 5631+/-154pg/ml  (p<0.05).  Further,  in  cells  pre-
incubated  with  NAC  the  effect  of  IL-1 β was  suppressed  significantly  (5669+/-
798pg/ml; p<0.05) as shown in Figure 4. 
Figure 4: IL-1β alone stimulation of IL-8 (CXCL8) and its inhibition by NAC pre-
incubation
Stimulation  of  IL-8  (CXCL8) with  IL-1β  and  hydrogen  peroxide  and  its 
inhibition with NAC:
To study the effect of antioxidant treatments on the production of chemokines, the 
above experiments were repeated on cells that were induced with IL-1β and H2O2 (30 
or 300  µM). A significant increase of IL-8 was observed in cells exposed to IL-1β 
alone.  However,  this  effect  was  partially  abolished  by NAC (Figure  5).  The IL-8 
generation  in  cells   stimulated with  30µM of  hydrogen peroxide  was  moderately 
inhibited in response to 10mM NAC pre-incubation  (2495+/1924pg/ml vs 3222+/-
12
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904pg/ml). In contrast, the IL-8 levels in cells stimulated with 300µM of hydrogen 
peroxide were significantly inhibited by NAC (1961+/-322pg/ml vs 4837+/-414pg/ml) 
as shown in Figure 5. The results demonstrate the role of oxidative stress induced by 
hydrogen  peroxide  in  mediating  IL-8  (CXCL8)  release  and  show a  dose  related 
response.
Figure 5: Suppression of H2O2 and IL-1β mediated production of IL-8 (CXCL8) 
by pre-incubation with NAC (N)
Oxidative stress and MCP-1 (CCL2) production
Effect of Hydrogen peroxide and IL-1β on MCP-1 (CCL2) 
MCP-1(CCL2) was investigated similar to previous experiments on IL-8  (CXCL8). 
There was no change in MCP-1 (CCL2) levels in response to either 30 or 300 µM of 
hydrogen peroxide (Figure 6). When cells were incubated with IL-1β they showed a 
significant  increase  in  MCP-1  (CCL2)  (2902+/-68pg/ml)  compared  to  the  control 
group (1616+/-54pg/ml) as shown in Figure 6. These results indicate that hydrogen 
peroxide has less involvement in MCP-1 (CCL2) production as compared to IL-8 
(CXCL8), however IL-1β  was able to potentiate its production suggesting different 
mechanisms maybe involved for hydrogen peroxide and IL-1β.
Figure 6: Induction of MCP-1 (CCL2) with IL-1β  but not with hydrogen peroxide 
Effect of pre-incubation with NAC and induction with hydrogen peroxide and IL-1β  on 
MCP-1 (CCL2)
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Pre-incubation with NAC resulted in a significant reduction of MCP-1 (CCL2) levels 
in  cells  exposed  to  300  µM  of  hydrogen  peroxide  (793.7+/-57pg/ml)  but  not  in 
response to 30 µM hydrogen peroxide (1172+/-109pg/ml) (Figure 7). These findings 
again suggest oxidative stress is involved, although pathways may possibly be more 
complex.  Pre-incubation  of  cells  with  NAC  also  resulted  in  inhibition  of  IL-1β 
induction although this was not statistically significant as shown in Figure 7.
Figure  7: Effect  of  pre-incubation  with  NAC  and  induction  with  Hydrogen 
peroxide and IL-1β on MCP-1 (CCL2) levels
Combined effect of H2O2, IL-1β , and NAC on MCP-1 (CCL2) 
The above experiments were repeated similar to the experiment with IL-8 (CXCL8) 
with the addition of cells stimulated with both IL-1β and hydrogen peroxide (30 and 
300 µM) and cells pre-incubated with 10mM NAC. Results were similar to those seen 
with  IL-8  (CXCL8).  IL-1β significantly  increased  the  MCP-1  (CCL2)  to  2902+/-
68pg/ml and NAC was able to inhibit this to a level of 2818+/-261pg/ml although 
again this was not statistically significant.  In the subset which were induced with 
hydrogen  peroxide  and  IL-1,  NAC  pre-incubation  caused  a  reduction  in  MCP-1 
(CCL2) in 300 µM group to 1044+/-303pg/ml when compared with the set which did 
not get NAC, 2636+/-177pg/ml (p<0.05) as shown in Figure 8.
Figure 8: Combined effect on MCP-1 production after NAC pre-incubation on 
IL-1β  and H2O2   stimulated cells
14
15
5. DISCUSSION
Oxidative stress resulting from IRI has been shown to have a major role in causing 
DGF  (21).  Chemokines  mediate  the  inflammatory  response  but  it  is  difficult  to 
establish a  detailed role  of  proximal  tubules.  Therefore,  a  simulated condition  of 
oxidative stress was attempted within the constraints of an in vitro model. HK-2 cells 
are a suitable model system for the purpose of these experiments because of their 
thorough characterisation, durability and consistent physiological response.
IRI  was  simulated  by  incubating  HK-2  cells  with  hydrogen  peroxide.  Hydrogen 
peroxide  introduced  exogenously  in  high  concentration  is  known  to  permeate 
through  cell  membranes  cannot  be  detoxified  to  water  by  the  intra-cellular 
antioxidant enzymes and produce oxidative stress (22). 
Hydrogen peroxide is converted by catalase and glutathione peroxidase to water. 
Glutathione peroxidase has been mainly shown to be produced in kidneys and HK-2 
cells  have been shown to  express glutathione peroxidase (23,24).  Several  other 
studies  have  also  reported  involvement  of  glutathione  peroxidase  in  defence 
responses  to  oxidative  stress  in  proximal  tubules  (25,26).Our  study  has  shown 
significant increase in  glutathione peroxidase from HK-2 cells  after induction with 
hydrogen peroxide.
Miguel et al have utilised hydrogen peroxide in a cell culture model of HeLa cells to  
study its effect on antioxidant enzymes. Hydrogen peroxide induced oxidative stress 
in a time- and concentration- dependent manner which was prevented with the use 
of the anti-oxidants ascorbic acid and N-acetyl cysteine (27).
There was no change in  catalase activity in  this  model.  There could  be several 
reasons  for  this  but  catalase  has  shown  to  be  less  responsive  in  experimental 
oxidative stress conditions due to differential inhibition (27). Catalase is also reported 
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to be inactivated by hydroxyl radicals, while glutathione peroxidase and superoxide 
dismutase (SOD) are considerably less affected by these radicals (28).
The observed basal secretion of IL-8 (CXCL8) by HK-2 cells is possibly the response 
of the cells to normal stress of growth inherent in cell culture systems. Bioprocess 
forces are known to be encountered during cell culture and include hydrodynamic 
shear  and  stresses  resulting  from  transfer  through  capillaries  or  by  pipetting  to 
suspend cell pellets (29). The progressive rise with time is the effect of accumulation. 
Andreucci et al also found a rise in IL-8 (CXCL8) after hydrogen peroxide stimulation 
in HK-2 cells (30). Shimada et al showed a similar rise from gastric epithelial cells 
when stimulated with hydrogen peroxide (31). DeForge et al showed the stimulatory 
effect  of  hydrogen  peroxide  on  IL-8  (CXCL8) production  by  HepG2  cells,  A549 
pulmonary type II epithelial cells, and human skin fibroblasts (32).
Cytokines like IL-1β, TNF or the bacterial product LPS in both a time- and dose-
dependent manner are known to increase expression of  IL-8  (CXCL8)  mRNA and 
secreting IL-8 (CXCL8) peptide (33). Ivison et al proved the link and mechanism of 
hydrogen peroxide mediated IL-8 (CXCL8) induction. This was dose dependent and 
associated with synergistic phosphorylation of p38 MAP kinase and with prolonged I-
κB degradation and NF-κB activation (34).
Enesa et al observed that H2O2 combined with cytokines (IL-1β, TNFα) induced IL-8 
(CXCL8) synergistically  in  cultured  epithelial  cells.  They  also  observed  that  the 
capacity  of  H2O2 to  enhance  IL-8  (CXCL8) induction  in  response  to  TNFα  was 
suppressed in cultures that were pre-treated with NAC (35).
Inhibition of MCP-1 (CCL2) signalling in ischemic renal injury has been shown to 
have a protective role (36). Takahashi et al have suggested JNK- and IκB-dependent 
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pathways regulate MCP-1 (CCL2) synthesis and also found NAC could suppress 
MCP-1 (CCL2) production (37).
NAC has also been shown to protect kidneys against oxidative damage from in vitro 
simulated  reperfusion  injury  (38).  Antonicelli  et  al  investigated  the  effect  of  
Nacystelyn, a recently developed lysine salt of NAC upon interleukin IL-8 (CXCL8) 
release and the activation of the re-dox-sensitive transcription factors AP-1, NF-κB, 
and C/EBP in a human alveolar epithelial cell line (A549)(39).
Ayvaz et al have reported the benefit of NAC in intestinal ischemic injury as well as,  
reperfusion in  rat  model  (40).  Similarly Nitescu et al  have shown NAC improves 
kidney function, and reduces renal interstitial inflammation, in rats subjected to renal 
IRI (41). Zhang et al found that NAC exerts its protective effect in part by directly 
scavenging ROS and in part via ERK1/2 activation in HK-2 cells (42) while Lee et al 
have shown NAC reduced Colistin induced nephrotoxicity in human proximal tubules 
(43).
Despite many favourable results in the  in  vitro models,  NAC has not  been used 
widely in the clinical world. So far it has shown some clinical benefit in preventing 
DGF and contrast nephropathy. (44-46 ). Briguori et al have reported that NAC was 
better than fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity 
(47).
Danilovic et al have shown clinical benefit of NAC in renal transplant recipients. Use 
of NAC resulted in reduced rate of DGF and better renal function was seen for up to  
one  year  (48).  NAC  administration  has  also  showed  an  improvement  in  the 
histopathological  findings  of  ischemia/reperfusion  damages  (40).  Donor  pre 
treatment with  NAC has been shown to  preserve renal  metabolism and improve 
outcomes of IRI  injured kidney transplants (49).  Fuentes et al  have shown NAC 
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treatment in patients with stable renal function after transplantation increased high-
density lipoprotein cholesterol and antioxidant molecules in relation to glutathione 
peroxidase, with a positive influence on renal function (50). However clinical trials 
have failed to show any benefit of using NAC as pre-treatment in deceased donors 
(51).
Although there is widespread involvement of ROS but there is a lack of widespread 
use of anti oxidants in clinical use. N-acetylcysteine, despite the growing evidence of 
benefit, has very limited utility used only for treating over-doses of acetaminophen 
and for improvement of bronchial mucous fluidity (52).
Many anti-oxidants show strong positive effects in the laboratory, but only a few of 
these drugs are used as anti-oxidants in humans. Some plausible reasons for this is 
that because  ROS production  occurs  ubiquitously  in  aerobic  cells  and  chemical 
reactivity of ROS takes place in a non-specific manner; to find statistically significant 
differences in different cells or tissues is difficult.  Because ROS production is very 
common and the human body has an abundant capacity for producing anti-oxidants, 
it  is  difficult  to obtain statistical  differences in trials designed to evaluate an anti-
oxidative drug.
Also even if expression of enzyme or protein is seen it may not necessarily result in 
an increase in activity (53).
Conclusion:
This study has shown that HK-2 cells are responsive to various physiological stimuli  
like  hydrogen  peroxide  and  cytokines.  IL-1β mediated  IL-8  production  is  partly 
mediated via oxidative radicals as NAC, a powerful antioxidant, was able to inhibit 
this reaction. Oxidative stress is possibly the underlying mechanism involved in the 
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various responses seen. The challenge remains in using these novel targets and 
their translation from bench to bedside (54). 
DGF  is  an  important  clinical  outcome  after  kidney transplantation,  and  one  that 
needs  to  be  addressed  by  funding agencies  and  clinical  trials. In  an  era  of 
tremendous shortage of kidneys for transplantation, every effort should be made  to 
improve the  survival  of  the  transplanted kidneys  in  the  recipient.  Therefore,  it  is 
imperative that we implement strategies to reduce the incidence of DGF in an effort 
to  improve  long-term graft  survival.  Cold  storage phase  is  indeed an underused 
therapeutic window.  High dosage of NAC can be delivered in cold perfusion fluids. 
The present  results  should be interpreted keeping in mind the constraints of  cell 
culture model.
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